Pneumo 23

Pneumococcal polysaccharide vaccine 23-valent · Merck & Co

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pneumo 23, covering 2015-06-18 to 2017-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of Immunological Memory Induced in Children by a Full 4 Dose Vaccination Schedule of 11 Valent Pneumococcal Conjugate Vaccine by Giving 1 Dose of Aventis Pasteur's 23-valent Pneumococcal Polysaccharide Vaccine (Pneumo 23) [Phase 3]

See pricing